NHS Digital FHIR Implementation Guide (Retired - 2.1.50)

This guidance is under active development by NHS Digital and content may be added or updated on a regular basis.

vaccination-covid19-2nd-dose

{
"resourceType": "Immunization",
"id": "551ef667-1402-4c92-ba34-a0bb88b998dc",
"extension": [
{
"url": "https://fhir.hl7.org.uk/StructureDefinition/Extension-UKCore-VaccinationProcedure",
"valueCodeableConcept": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "1324691000000104",
"display": "Administration of second dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccine"
}
]
}
}
],
"identifier": [
{
"system": "https://tools.ietf.org/html/rfc4122",
"value": "7ec28d82-33bf-4e6d-a8de-91dcbc8d1802"
}
],
"status": "completed",
"primarySource": false,
"reportOrigin": {
"text": "RR8 - LEEDS TEACHING HOSPITALS NHS TRUST"
},
"occurrenceDateTime": "2021-02-23T13:00:08.476+00:00",
"patient": {
"reference": "Patient/1953684",
"type": "Patient",
"identifier": {
"system": "https://fhir.nhs.uk/Id/nhs-number",
"value": "9912003888"
}
},
"vaccineCode": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "39114911000001105",
"display": "COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)"
}
]
},
"manufacturer": {
"display": "DREAMLAND Pharmaceuticals Ltd"
},
"lotNumber": "R04X",
"protocolApplied": [
{
"doseNumberPositiveInt": 2
}
]
}
<Immunization xmlns="http://hl7.org/fhir">
<id value="551ef667-1402-4c92-ba34-a0bb88b998dc" />
<extension url="https://fhir.hl7.org.uk/StructureDefinition/Extension-UKCore-VaccinationProcedure">
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct" />
<code value="1324691000000104" />
<display value="Administration of second dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccine" />
</coding>
</valueCodeableConcept>
</extension>
<identifier>
<system value="https://tools.ietf.org/html/rfc4122" />
<value value="7ec28d82-33bf-4e6d-a8de-91dcbc8d1802" />
</identifier>
<status value="completed" />
<vaccineCode>
<coding>
<system value="http://snomed.info/sct" />
<code value="39114911000001105" />
<display value="COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)" />
</coding>
</vaccineCode>
<patient>
<reference value="Patient/1953684" />
<type value="Patient" />
<identifier>
<system value="https://fhir.nhs.uk/Id/nhs-number" />
<value value="9912003888" />
</identifier>
</patient>
<occurrenceDateTime value="2021-02-23T13:00:08.476+00:00" />
<primarySource value="false" />
<reportOrigin>
<text value="RR8 - LEEDS TEACHING HOSPITALS NHS TRUST" />
</reportOrigin>
<manufacturer>
<display value="DREAMLAND Pharmaceuticals Ltd" />
</manufacturer>
<lotNumber value="R04X" />
<protocolApplied>
<doseNumberPositiveInt value="2" />
</protocolApplied>
</Immunization>
Immunization
back to top